Establishment Labs (ESTA) Projected to Post Earnings on Wednesday

Establishment Labs (NASDAQ:ESTA) will likely be posting its Q1 2025 quarterly earnings results after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of ($0.83) per share and revenue of $41.15 million for the quarter.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm had revenue of $44.51 million during the quarter, compared to analysts’ expectations of $44.45 million. On average, analysts expect Establishment Labs to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Establishment Labs Stock Down 0.7 %

Shares of ESTA traded down $0.24 during trading on Monday, reaching $33.16. The company’s stock had a trading volume of 87,986 shares, compared to its average volume of 460,226. The company has a market cap of $956.39 million, a price-to-earnings ratio of -12.85 and a beta of 0.73. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The company has a fifty day moving average of $35.67 and a two-hundred day moving average of $38.83. Establishment Labs has a twelve month low of $26.56 and a twelve month high of $60.12.

Analysts Set New Price Targets

A number of research analysts have commented on ESTA shares. Needham & Company LLC initiated coverage on Establishment Labs in a report on Monday, April 14th. They set a “hold” rating on the stock. Stephens restated an “overweight” rating and set a $52.00 price objective on shares of Establishment Labs in a research note on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $57.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.